NovoCure (NVCR) Earnings Date, Estimates & Call Transcripts $12.34 +0.43 (+3.61%) (As of 01:27 PM ET) Add Compare Share Share Today's Range$11.29▼$12.3650-Day Range$11.13▼$18.1852-Week Range$10.87▼$120.03Volume602,013 shsAverage Volume1.39 million shsMarket Capitalization$1.32 billionP/E RatioN/ADividend YieldN/APrice Target$45.29 EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateFeb. 22EstimatedActual EPS (Oct. 26) -$0.46 Beat By $0.05 Consensus EPS (Oct. 26) -$0.51 Read Call TranscriptListen to CallLatest SEC 10-Q Filing Get NovoCure Earnings AlertsEnter your email address below to receive the latest news and earnings results for NVCR and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueNVCR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.NVCR Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. NovoCure Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20231$0.00$0.00$0.00 Q2 20232($0.50)$0.01($0.25) Q3 20233($0.57)$0.03($0.34) Q4 20233($0.60)$0.05($0.34) FY 20239($1.67)$0.09 ($0.93)NVCR Earnings Date and InformationNovoCure last released its earnings data on October 26th, 2023. The medical equipment provider reported ($0.46) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.51) by $0.05. The company earned $127.30 million during the quarter, compared to the consensus estimate of $128.75 million. Its quarterly revenue was down 2.8% compared to the same quarter last year. NovoCure has generated ($1.86) earnings per share over the last year (($1.86) diluted earnings per share). Earnings for NovoCure are expected to decrease in the coming year, from ($2.01) to ($2.17) per share. NovoCure has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 22nd, 2024 based off prior year's report dates.Read More NovoCure Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 2/22/2024Estimated)------- 10/26/2023Q3 2023($0.51)($0.46)+$0.05($0.46)$128.75 million$127.30 million 7/27/2023Q2 2023($0.50)($0.54)($0.04)($0.54)$124.25 million$126.05 million 5/4/2023Q1 2023($0.36)($0.50)($0.14)($0.50)$127.93 million$122.20 million 2/23/2023Q4 2022($0.32)($0.36)($0.04)($0.36)$127.20 million$128.43 million 10/27/2022Q3 2022($0.30)($0.25)+$0.05($0.25)$134.83 million$131.00 million7/28/2022Q2 2022($0.14)($0.23)($0.09)($0.23)$135.13 million$140.90 million Get the Latest News and Ratings for NVCR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NovoCure and its competitors with MarketBeat's FREE daily newsletter. 4/28/2022Q1 2022($0.17)($0.04)+$0.13($0.04)$134.29 million$137.50 million 2/24/2022Q4 2021($0.10)($0.25)($0.15)($0.25)$134.49 million$133.20 million 10/28/2021Q3 2021($0.06)($0.13)($0.07)($0.13)$141.22 million$133.61 million 7/29/2021Q2 2021$0.02($0.14)($0.16)($0.14)$141.50 million$133.52 million 4/29/2021Q1 2021$0.02($0.04)($0.06)($0.04)$136.54 million$134.70 million 2/25/2021Q4 2020$0.13$0.04($0.09)$0.04$143.49 million$144.00 million NovoCure Earnings - Frequently Asked Questions When is NovoCure's earnings date? NovoCure has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 22nd, 2024 based off last year's report dates. Learn more on NVCR's earnings history. Did NovoCure beat their earnings estimates last quarter? In the previous quarter, NovoCure (NASDAQ:NVCR) reported ($0.46) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.51) by $0.05. Learn more on analysts' earnings estimate vs. NVCR's actual earnings. How can I listen to NovoCure's earnings conference call? The conference call for NovoCure's latest earnings report can be listened to online. Listen to Conference Call How can I read NovoCure's conference call transcript? The conference call transcript for NovoCure's latest earnings report can be read online. Read Transcript How can I view NovoCure's earnings report? NovoCure's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does NovoCure generate each year? NovoCure (NASDAQ:NVCR) has a recorded annual revenue of $537.84 million. How much profit does NovoCure generate each year? NovoCure (NASDAQ:NVCR) has a recorded net income of -$92.53 million. NVCR has generated -$1.86 earnings per share over the last four quarters. What is NovoCure's EPS forecast for next year? NovoCure's earnings are expected to decrease from ($2.01) per share to ($2.17) per share in the next year. More Earnings Resources from MarketBeat Related Companies: TNDM Earnings LMAT Earnings ATEC Earnings EMBC Earnings PRCT Earnings FNA Earnings KIDS Earnings SIBN Earnings AORT Earnings ATRC Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Alibaba is down more than 10% since earnings, now what?2 stocks that faded their price gaps after crushing earnings Can Kohl's keep its momentum after earnings dip?Nvidia's earnings, dominance, growth and global challenges$20 looks like a good fit for The Gap after XL earnings beatRenovating returns: Lowe's earnings and the DIY dilemma3 stocks that crushed earnings estimates and still tanked This page (NASDAQ:NVCR) was last updated on 11/28/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovoCure Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.